Patent · US Active

Zika virus MRNA vaccines

US10653767B2 · kind B2 · utility

65Cited by
32References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2018
Grant dateMay 19, 2020
Priority date—
Expiry dateSep 14, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein, in some embodiments, are Zika virus RNA vaccines and methods of producing an antigen-specific immune response in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.